fibrosis

New Ultrasensitive Biosensor Detects Early-Stage Liver Fibrosis via Blood Test

by

Researchers at Sungkyunkwan University (SKKU), in collaboration with the Catholic University of Korea and Eunpyeong St. Mary’s Hospital, have developed an ultrasensitive electrochemical biosensor capable of detecting early-stage liver fibrosis through a small blood sample. The device, known as FIB-EIS, identifies the protein PICP to signal liver hardening, potentially replacing invasive tissue biopsies with a … Read more

Space Travel and Aging: How Liver Changes Unlock New Clues

by

Exposure to space radiation and microgravity triggers rapid genetic changes in the liver that mirror the human aging process, according to research published in the journal GeroScience. How does space travel accelerate the aging process? Space environments force the human body to endure conditions that trigger premature biological decline. Michal Masternak, a professor of medicine … Read more

Key Cells Driving Hypertrophic Scarring Identified

by

Researchers at the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences have identified a specific fibroblast cell state—designated as “Fib_5”—that serves as a primary driver of hypertrophic scar formation. Published in Burns & Trauma in 2026, the study reveals that the transcription factor Yin Yang 1 (YY1) acts as a molecular “brake” on … Read more

Herbal Extract Shows Promise in Treating Chronic Renal Failure

by

Targeting Aging: A New Frontier in Treating Chronic Renal Failure Chronic renal failure (CRF) remains a formidable medical challenge, marked by a progressive, irreversible decline in kidney function. As current therapeutic options often fall short of halting disease progression, researchers are increasingly looking toward the biological mechanisms of aging as a potential pathway for intervention. … Read more

New Pulmonary Surfactant Nanoparticles for Lung Disease Treatment

by

The Future of Lung Care: How Biomimetic Nanotech is Changing the Game For decades, the standard treatment for pulmonary fibrosis—a condition characterized by the progressive scarring of lung tissue—has relied heavily on oral medications. While effective for some, these drugs often come with a heavy price: systemic side effects that impact the liver and other … Read more

Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C

by

The New Frontier of Hepatitis C Treatment: Breaking the Barrier of “Difficult-to-Treat” Strains For years, the medical community has chased the “holy grail” of Hepatitis C (HCV) treatment: a regimen that is not only highly effective across all genotypes but also safe for patients with complex comorbidities. Recent real-world data from a multicenter study in … Read more

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

by

The Future of Metabolic Health: Beyond GLP-1, Towards Comprehensive Solutions A landmark review published in The Lancet confirms what many clinicians are witnessing: modern incretin-based drugs are fundamentally changing how we approach obesity, type 2 diabetes (T2D), and related health issues. But the story doesn’t end with semaglutide and tirzepatide. The research points towards a … Read more

New pathway found connecting liver congestion to fibrosis and cancer

by

Unlocking the Secrets of Liver Congestion: A New Pathway to Treatment Chronic liver congestion, a condition where blood pools in the liver, has long been recognized as a precursor to severe liver diseases like fibrosis and even cancer. However, the precise mechanisms driving this progression have remained elusive – until now. Researchers at The University … Read more

Engineers develop highly precise gene editor for safer cystic fibrosis treatments

by

Gene Editing Precision: A New Era for Cystic Fibrosis and Beyond A significant leap forward in gene-editing technology is offering renewed hope for individuals with cystic fibrosis (CF) and a broader range of genetic diseases. Researchers at the University of Pennsylvania and Rice University have refined a technique to edit individual genetic “base pairs” with … Read more

Taupō woman with cystic fibrosis competing in Ironman next month

by

From Endurance Athlete to Advocate: How Trikafta is Rewriting the Future for Cystic Fibrosis Kirsty Parsons, a 32-year-old from Taupō, New Zealand, is preparing to make history. On March 7, 2026, she will compete in Ironman New Zealand, aiming to become the first woman in the country with cystic fibrosis (CF) to complete the grueling … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]